PMID: 9450795Feb 5, 1998Paper

Epoetin alfa and beta differ in their erythropoietin isoform compositions and biological properties

British Journal of Haematology
Patrick L StorringJ Lee

Abstract

Epoetin alfa and beta are the two forms of recombinant DNA-derived erythropoietin (rEPO), both synthesized in Chinese hamster ovary cells, which are used for the treatment of erythropoietin (EPO)-responsive anaemias. Several batches of each of these rEPOs were compared for differences in their EPO isoform compositions by isoelectric focusing (IEF) and in a range of lectin-binding assays, and for differences in their EPO activities by in-vivo and in-vitro mouse bioassays and by immunoassay. Epoetin beta was found to differ from epoetin alfa in containing: (a) a greater proportion of more basic isoforms, (b) a greater proportion of EPO binding to Erythrina cristagalli agglutinin (which binds N-glycans with nonsialylated outer Gal beta1-4GlcNAc moieties), and (c) isoforms with higher in-vivo:in-vitro bioactivity ratios. Epoetin beta also contained slightly more than epoetin alfa of EPO binding to Lycopersicon esculentum agglutinin (which binds N-glycans containing repeating Gal beta1-4GlcNAc sequences), to the leucoagglutinin of Phaseolus vulgaris (which binds tetraantennary and 2,6-branched triantennary N-glycans) and to Agaricus bisporus agglutinin (which binds Gal beta1-3GalNAc containing O-glycans). No differences were found b...Continue Reading

Citations

Jul 20, 2002·Clinical Journal of Sport Medicine : Official Journal of the Canadian Academy of Sport Medicine·Rymantas KazlauskasGraham Trout
Sep 19, 2003·Current Medical Research and Opinion·Anton Haselbeck
Oct 25, 2003·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·A S RamosS L Dalmora
Aug 4, 2005·Annals of Hematology·Michael Heuser, Arnold Ganser
Aug 9, 2005·Expert Opinion on Emerging Drugs·John A Glaspy
Jun 14, 2006·Critical Reviews in Clinical Laboratory Sciences·Giuseppe LippiGian Cesare Guidi
Mar 8, 2006·Nature Clinical Practice. Oncology·Julia BohliusAndreas Engert
Sep 12, 2007·Bone Marrow Transplantation·T J Littlewood, G P Collins
Mar 26, 2008·British Journal of Pharmacology·S Elliott
Jul 10, 2009·The Cochrane Database of Systematic Reviews·Julia BohliusAndreas Engert
Apr 1, 2010·Drug Testing and Analysis·Stefan E Franz
Mar 21, 2012·Analytical and Bioanalytical Chemistry·Angelina TaichribChristian Neusüß
Sep 6, 2014·Applied Health Economics and Health Policy·François BocquetClaude Le Pen
Feb 1, 2018·Biotechnology and Bioengineering·Chandrasekhar GurramkondaGovind Rao
Feb 6, 2007·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Carsten Oberhoff
Aug 8, 2006·Nephrology·Simon D Roger
Dec 2, 2008·Expert Opinion on Drug Delivery·Zhi-Yang ChangMing-Kung Yeh
Aug 14, 2010·American Journal of Hematology·Wolfgang Jelkmann
Feb 20, 2009·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Wolfgang Jelkmann
Apr 14, 2010·Expert Opinion on Biological Therapy·Simon D Roger
Feb 3, 2012·Expert Opinion on Pharmacotherapy·Francesco Locatelli, Lucia Del Vecchio
Feb 22, 2013·Bioanalysis·Meena Subramanyam
Mar 4, 2014·Expert Opinion on Biological Therapy·Lucia Del Vecchio, Francesco Locatelli
Feb 28, 2019·Biotechnology Letters·Jana AdamíkováMilan Polakovič
Aug 28, 2003·Artificial Organs·Francesco Locatelli, Lucia Del Vecchio
Dec 8, 2009·Medicinal Research Reviews·Ainhoa MuruaJosé Luis Pedraz
Jun 7, 2005·Journal of the American Society of Nephrology : JASN·Nicole CasadevallJérôme Rossert
Apr 11, 2003·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Kai-Uwe Eckardt, Nicole Casadevall
Apr 7, 2005·Journal of the National Cancer Institute·Julia BohliusAndreas Engert
Aug 1, 2009·Expert Review of Hematology·Francesco Locatelli, Lucia Del Vecchio
Mar 30, 2011·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Kwang Seok SeoJai Myung Yang
Oct 15, 2013·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Masaru EnomotoNorifumi Kawada
Oct 5, 2011·The Oncologist·Francesco Locatelli, Lucia Del Vecchio

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.